7 trends tracked about this subject — the full history, oldest to newest below.
The FDA has granted accelerated approval to Bristol Myers Squibb's Zenbexus, introducing a novel CELMoD drug class for multiple myeloma treatment.
4 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Pharmaceutical leader Bristol Myers Squibb is investing $2.3 billion to establish a massive new manufacturing campus in Houston, Texas.
Analysts express perplexity as reports indicate active merger talks between Bristol-Myers Squibb and AstraZeneca.
AstraZeneca shares have declined following reports of potential $400 billion merger talks with Bristol Myers Squibb.
Bristol Myers Squibb is partnering with Nvidia to construct what it claims will be the most powerful AI supercomputer in the pharmaceutical industry.
A US House committee has launched an investigation into major pharmaceutical companies regarding the use of clinical trial sites in China.